 |
PDBsum entry 2a2c
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The molecular architecture of human n-Acetylgalactosamine kinase.
|
 |
|
Authors
|
 |
J.B.Thoden,
H.M.Holden.
|
 |
|
Ref.
|
 |
J Biol Chem, 2005,
280,
32784-32791.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Galactokinase plays a key role in normal galactose metabolism by catalyzing the
conversion of alpha-d-galactose to galactose 1-phosphate. Within recent years,
the three-dimensional structures of human galactokinase and two bacterial forms
of the enzyme have been determined. Originally, the gene encoding galactokinase
in humans was mapped to chromosome 17. An additional gene, encoding a protein
with sequence similarity to galactokinase, was subsequently mapped to chromosome
15. Recent reports have shown that this second gene (GALK2) encodes an enzyme
with greater activity against GalNAc than galactose. This enzyme, GalNAc kinase,
has been implicated in a salvage pathway for the reutilization of free GalNAc
derived from the degradation of complex carbohydrates. Here we report the first
structural analysis of a GalNAc kinase. The structure of the human enzyme was
solved in the presence of MnAMPPNP and GalNAc or MgATP and GalNAc (which
resulted in bound products in the active site). The enzyme displays a distinctly
bilobal appearance with its active site wedged between the two domains. The
N-terminal region is dominated by a seven-stranded mixed beta-sheet, whereas the
C-terminal motif contains two layers of anti-parallel beta-sheet. The overall
topology displayed by GalNAc kinase places it into the GHMP superfamily of
enzymes, which generally function as small molecule kinases. From this
investigation, the geometry of the GalNAc kinase active site before and after
catalysis has been revealed, and the determinants of substrate specificity have
been defined on a molecular level.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
FIGURE 1. Ribbon representation of human GalNAc kinase.
Human GalNAc kinase folds into two motifs referred to as the N-
and C-terminal domains. As indicated in a, the N-terminal domain
is dominated by a seven-stranded mixed -sheet highlighted in
magenta. Two layers of antiparallel -sheet, colored in
yellow and blue, characterize the C-terminal domain. The
location of the active site is indicated by the ball-and-stick
representations for GalNAc-1-phosphate and MgADP, with the Mg2+
ion highlighted in green. Electron density corresponding to
GalNAc 1-phosphate and MgADP is displayed in b. While the
protein was crystallized in the presence of GalNAc and MgATP,
the electron density clearly reveals that the enzyme is active
in the crystalline lattice. The map, contoured at 2 , was
calculated with coefficients of the form F[o] - F[c], where F[o]
was the native structure factor amplitude, and F[c] was the
calculated structure factor amplitude from the model lacking
coordinates for the ligands. A close-up view of the active site
with bound products is depicted in c. Only those residues
located within 3.2 Å of the
ligands are shown. The green dashed lines indicate coordinate
covalent bonds between the magnesium ion and its ligands. The
black dashed lines indicate potential hydrogen bonding
interactions. For clarity, Ser141 and Gly143 were omitted from
the figure.
|
 |
Figure 3.
FIGURE 3. A comparison of human galactokinase versus GalNAc
kinase. The human forms of galactokinase and GalNAc kinase
differ in three specific regions labeled A, B, and C and
indicated by the blue ribbons in a. A superposition of the sugar
binding regions for these enzymes is given in b. The yellow
bonds correspond to GalNAc kinase, with the sugar ligand
depicted in aquamarine. The white bonds correspond to
galactokinase, with the sugar ligand highlighted in magenta. The
red and black labels correspond to residues in galactokinase and
GalNAc kinase, respectively. Coordinates for the human
galactokinase were from this laboratory (Protein Data Bank
accession number 1WUU [PDB]
).
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
32784-32791)
copyright 2005.
|
 |
|
|
|
|
 |